Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "VIKING"


25 mentions found


Courtesy Port Ellen DistilleryAcross the courtyard, the new still room resembles a vast industrial greenhouse with four shiny new copper stills as its exotic plants. “It is important that we recreate that classic Port Ellen character that people love, but we also want to be doing things we’ve not done before,” says McDonald. Courtesy Port Ellen DistilleryA glimpse into that past comes in the musky surroundings of warehouse number two with a dram drawn straight from a cask filled in 1979. Port Ellen is hoping to attract upscale whisky fans to sample a by-appointment-only Atlas of Smoke Experience. “At the moment, Port Ellen is expensive because it is so old and so rare.
Persons: Carol Ann Duffy’s, ” “, Ellen, , attar, Port Ellen, Roy Duff, Dramface.com, Ardbeg, Hijiri, Alexander McDonald, McDonald, Port, Port Ellen Gemini, Ellens, There’s, Dramface’s Duff, ” Emily Burnham, Organizations: Scotland CNN, Port, Ellen, Diageo, North America —, Smoke Locations: Islay, Scotland, Isle of Islay, Wuyi, Port, Scottish, , Highland, Brora, Falkirk, Scotland’s, Hong Kong, Kilnaughton Bay, Antrim, Northern Ireland, Mull, Kintyre, North, America, United States
Two months ago, I wrote a story entitled, "The IPO market is looking very shaky and facing challenges galore." Two months later, the IPO market is still shaky, but there are definite signs of improvement. Second, three $100 million IPOs have filed to go public in the past week, including Viking (the cruise line operator) and Rubrik, a data management platform. Greg Martin at Rainmaker Securities told me that the recent performance of Reddit and Astera Labs, "Were nice shots in the arm for the IPO market. Even with markets at new highs, the specter of interest rates creeping up is still hanging over the IPO market.
Persons: Matt Kennedy, Reddit, Greg Martin, Ibotta, Ingram, Del, Viking, Howe Ng, I'm, Martin, Rainmaker, Santosh Rao Organizations: IPOs, Viking, Renaissance Capital, Astera Labs, Rainmaker Securities, NYSE, UL Solutions, Underwriters Laboratories, Nursing, Centuri Holdings, Labs, Companies, Ingram Micro, Epic, Manhattan Venture Partners Locations: IPOs, Del Monte
Weight-loss drugs like Ozempic, Wegovy, and Mounjaro are all the rage, and investors are noticing. Since launching in November, the Tema Obesity and Cardiometabolic ETF (HRTS) is up 24%, crushing the S&P 500's 14.8% returns over the same period. Pot and his colleagues at Tema are bullish on the weight-loss drug stocks due to the wave of demand they see coming. Novo Nordisk estimates that only 2% of obesity cases are being treated by weight-loss drugs, Pot said. 4 weight-loss drug stocks to watchPot listed two larger stocks and two smaller ones in the space.
Persons: Maurits Pot, Janus Henderson, Pot, Goldman Sachs, Geoff Meacham, Charles Barkley, Elon Musk, Whoopi Goldberg, Eli Lilly, Lilly Organizations: VanEck Pharmaceutical, Business, World Health Organization, Novo Nordisk, Bank of America, Bank, Nordisk, FDA, Amazon, Therapeutics, Zealand Pharma Locations: Tema, GLP, Danish, it's
Robinhood — Shares of the brokerage firm jumped more than 6% after unveiling its Robinhood Gold Card, a credit card where cash back can be deposited into a brokerage account. Concentrix — Shares slipped nearly 4% on the back of disappointing fiscal second-quarter earnings guidance. The customer experience technology company also reiterated its full-year outlook for 2024. In the prior session , the stock popped more than 15% on promising trial results for a weight loss pill. Trump Media & Technology Group — Shares of former President Donald Trump's social media company climbed nearly 14% after making its debut as a publicly traded company a day earlier.
Persons: Krispy, McDonald's, Morgan Stanley, Donald Trump's, — CNBC's Michelle Fox, Sarah Min, Jesse Pound Organizations: GameStop, Moderna, Blackstone Life Sciences, Viking Therapeutics, Deutsche Bank, Trump Media & Technology, Merck, Food and Drug Administration, FactSet
CNN —Ukraine’s soccer team qualified for this summer’s European Championships with a come-from-behind win over Iceland, a rare moment of joy for the country more than two years into Russia’s invasion. Coach Sergiy Rebrov’s players made a ring around the center circle to lead the fans in a ‘Viking thunder clap’, the celebration made famous by their defeated opponents Iceland at Euro 2016. Ukraine finished third in their qualifying group, behind England and Italy, but beat Bosnia-Herzegovina in an earlier play-off to set up the decisive clash with Iceland. Russia will not be taking part, having been banned by European governing body UEFA because of the invasion. Ukraine will play in Group E of Euro 2024, along with Belgium, Slovakia and Romania, and face the prospect of taking to the continental stage while war rages back home.
Persons: Mykhailo Mudryk, Mudryk, Sergiy, Albert Gudmundsson, Viktor Tsyhankov’s, Volodymyr Zelensky, , Zelensky, Oleksandr Zinchenko Organizations: CNN, Chelsea, Iceland, Ukraine, , UEFA Locations: Iceland, Wroclaw, Poland, Ukraine, England, Italy, Bosnia, Herzegovina, “ Ukraine, Germany, Europe, Russia, Belgium, Slovakia, Romania, Avdiivka, Western, Israel, Gaza
Viking Therapeutics shares jumped more than 25% on Tuesday after the company said its experimental weight loss pill showed positive results in a small study and will enter the next stage of development later this year. The study results add to the excitement around the drugmaker's prospects in the budding weight loss drug market. Based on Tuesday's results, Viking plans to start a phase two trial of its weight loss pill later this year. Weight loss for those patients ranged up to 3.6% higher than those who received a placebo. Viking CEO Brian Lian said during a conference call on Tuesday that it's unclear "how durable" the weight loss is.
Persons: Eli Lilly, Viking, Brian Lian Organizations: Viking Therapeutics, Novo Nordisk, Viking
Topping the tape: Viking soars on oral weight loss drug
  + stars: | 2024-03-26 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailTopping the tape: Viking soars on oral weight loss drugThe 'Fast Money' traders weigh in on Viking Thera stock soaring on its obesity pill data.
Locations: Viking
Krispy Kreme — Krispy Kreme popped nearly 30% and headed for its best day on record. Trump Media & Technology Group — Shares of former President Donald Trump's social media company surged 35% after it began trading on the Nasdaq . Trump Media completed its merger with shell company Digital World Acquisition Corp . McCormick — The stock jumped 10% after the spice maker topped earnings and revenue expectations for its fiscal first quarter. Reddit — Reddit popped about 15% as investors continued buying up the social media stock following its Thursday debut on the New York Stock Exchange .
Persons: Kreme, McDonald's, Donald Trump's, McCormick, Morgan Stanley, Alex Harring, Michelle Fox, Jesse Pound, Pia Singh Organizations: Trump Media & Technology, Nasdaq, Trump Media, Revenue, New York Stock Exchange, Viking Therapeutics, Seagate Technology, Micron Technology, Mizuho Securities, UPS —, UPS, JPMorgan Locations: FactSet
Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. Finally, Viking Therapeutics soared more than 25% after reporting encouraging Phase 1 results of its oral weight loss pill. The data showed up to 5.3% weight loss at 28 days. Its Phase 2 results up to 14.7% mean weight loss at 36 weeks. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER .
Persons: Jim Cramer, Larry Fink, It's, Wedbush, Jim, Eli Lilly, Jim Cramer's Organizations: CNBC, BlackRock, Census Bureau, Social Security, Microsoft, Justice Department, Viking Therapeutics
London CNN —Microplastics have been found in historic soil samples for the first time, according to a new study, potentially upending the way archaeological remains are preserved. In total, the study identified 16 different microplastic polymer types in contemporary and archived soil samples, the statement adds. While preserving archaeological remains in situ has been the favored approach in recent years, the new findings could trigger a change in approach, as microplastic contamination could compromise the remains’ scientific value. “The presence of microplastics can and will change the chemistry of the soil, potentially introducing elements which will cause the organic remains to decay. If that is the case, preserving archaeology in situ may no longer be appropriate.”The study was published in Science of the Total Environment.
Persons: London CNN —, ” John Schofield, ” David Jennings, , , Organizations: London CNN, University of York, University of York’s Department of Archaeology, York, Environment Locations: London, United Kingdom, Coppergate, York
Mario Tama | Getty ImagesAmgen is taking a new approach as it tries to stand out in a crowded field of drugmakers racing to develop the next blockbuster weight loss drug. It's too early to say how competitive Amgen will be in the budding weight loss drug space, which Novo Nordisk and Eli Lilly have so far dominated. Goldman Sachs also projects that between 10 million and 70 million Americans will be taking weight loss drugs by 2028. The sustained weight loss in Amgen's study appears to contrast with results seen in clinical trials on Zepbound and Wegovy. An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023.
Persons: Mario Tama, Eli Lilly, Goldman Sachs, Zepbound, Eli Lilly's, Amgen's MartiTide, Caroline Apovian, Apovian, Joe Buglewicz, MariTide, Holly Lofton, Eli Lilly’s, Brendan McDermid, Reuters Amgen's, William Blair, Matt Phipps, Phipps Organizations: Getty, Novo Nordisk, Pfizer, Viking Therapeutics, Therapeutics, Zealand Pharma, Boehringer, Center, Weight Management, Wellness, Brigham, Women's, Washington Post, NYU Langone Health, Reuters, William Blair & Company, CNBC Locations: Thousand Oaks , California, Oaks , California, Novo, New York City, U.S
The long, thin piece of metal looked like a scaffolding pole when Trevor Penny saw it on the banks of an English river last November. That would not have surprised Mr. Penny, who, while practicing his magnet fishing hobby, has unearthed household items, tools and other metal debris from the waterways near his Oxfordshire home. (Magnet fishing is pretty much what it sounds like: A strong magnet is attached to a rope, which is then tossed into a body of water.) But his find that day was much more dramatic: a rusty Viking sword that had been there for more than 1,000 years. The sword, found in the River Cherwell and identified by an archaeological group that tracks public finds, most likely dates to a period between 850 A.D. and 975 A.D. Mr. Penny said he handed it over to the Oxfordshire Museums Service this week, where it is expected to be put on display after restoration.
Persons: Trevor Penny, Penny Organizations: Oxfordshire Museums Service Locations: Oxfordshire, Cherwell
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThree-Stock Lunch: Super Micro Computer, Deckers Outdoor, and Viking TheraJerry Castellini, CastleArk Management co-founder, joins 'Power Lunch' to discuss plays for three stocks, including Super Micro Computer, Deckers Outdoor, and Viking Thera.
Persons: Jerry Castellini Organizations: Computer, CastleArk Management, Micro Computer Locations: Viking
Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. Jim Cramer said the stock is a must-own tied to energy and oil. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER .
Persons: Jim Cramer, Dow, Eaton, Locker, Jerome Powell, Jim, Thomas Jorden, Eli Lilly, Lilly, Jim Cramer's Organizations: CNBC, Nasdaq, Nvidia, Broadcom, Costco, Capitol, Coterra Energy, Management, Wall, UBS, Club, Therapeutics Locations: AVGO, FL
In this article VKTX Follow your favorite stocks CREATE FREE ACCOUNTCr | Istock | Getty ImagesBiotech company Viking Therapeutics has emerged as a strong potential entrant — or takeover target — in the budding weight loss drug market. Their treatments sparked the weight loss drug industry gold rush over the past year despite their hefty price tags and barriers to insurance coverage. It's too early to say whether Viking's drug could have an edge over existing or developing weight loss treatments. The pharmaceutical giant could also launch a slate of other weight loss treatments over the next few years that may have advantages over Zepbound, whether they offer more weight loss or convenience. That could give Viking the commercial and manufacturing capabilities needed to compete in the weight loss drug market.
Persons: Eli Lilly, Eli Lilly's Zepbound, Viking, Goldman Sachs, Eli Lilly’s, Brendan Mcdermid, GLP, Brian Lian, William Blair, Andy Hsieh, Hsieh, Eli Lilly's, Jefferies, Akash Tewari, doesn't, Mike Segar, Lian, William Blair's Hsieh, Oppenheimer, Jay Olson Organizations: Getty Images Biotech, Viking Therapeutics, Novo Nordisk, Reuters, Viking, Novo, U.S . Food, Drug Administration, Company, Deutsche Bank, CNBC Locations: New York City, Branchburg , New Jersey
I love my Costco membership, especially because I get access to the Costco Next program. Costco Next offers members limited-time deals from name brands, like Viking and Travelpro. I saved thousands buying a shed through Costco Next, and I regularly see 40% discounts on products. I've also seen offers available for discounted caskets, playhouses, bicycles, phone cases, slippers, and baby toys. Viking; Costco NextCostco Next offers vary, but I've seen many products for 30% to 50% off their original price.
Persons: , It's, I've, Dearforms Organizations: Costco, Costco Next, Service
With Covid-19 disruptions in the rearview mirror and the cruise industry back on track, another cruise line has taken a step towards possibly going public. Melius Research believes a Viking IPO makes rational sense. Norwegian Cruise Line , whose recovery has lagged its rivals, reported on Tuesday its first profitable year since 2019 . While shares of Norwegian, Royal Caribbean and Carnival are all down so far this year, they had a blockbuster 2023. A Viking IPO could bring both," he said.
Persons: Conor Cunningham, Cunningham Organizations: Viking Holdings, U.S . Securities, Exchange Commission, Research, Norwegian Cruise, Norwegian, Royal, Royal Caribbean, Carnival Locations: Norwegian, Royal Caribbean
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street.
Persons: Jim Cramer, Dow, Jim, Chris Danely, Cramer, Eaton, Eli Lilly, Lilly, Jim Cramer's Organizations: CNBC, Dow, Nasdaq, Semiconductor, Citi, Broadcom, Nvidia, Devices, Micron, Dell Technologies, Autodesk, Novo Nordisk, Abbott Laboratories, Novo, Viking, Jim Cramer's Charitable
Biotech company Viking Therapeutics saw stock prices double after a report on weight loss drug VK2735. The new drug could lead to even more weight loss at a faster pace than Ozempic or Mounjaro. Viking Therapeutics, a small California-based biotech company, shared the topline results from a mid-stage trial of its drug VK2735 on February 27. AdvertisementHowever, the early results of clinical trials suggest it could be on par to offer even more weight loss in less time than its competitors. How Viking Therapeutics' weight-loss drug worksVK2735 mimics two hormones that affect weight control.
Persons: , Eli Lilly, GIP, VK2735 Organizations: Biotech, Viking Therapeutics, Service, Novo Nordisk, Washington Post, Therapeutics, Viking Locations: California
Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. Eli Lilly shares fell 1% on Wednesday following a similar drop in the prior session. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.
Persons: Jim Cramer, Salesforce, Jim, Let's, Eli Lilly, Jim Cramer's Organizations: CNBC, TJX Companies, Management, Therapeutics Locations: GLP
Cramer’s Stop Trading: Viking Therapeutics
  + stars: | 2024-02-27 | by ( ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCramer’s Stop Trading: Viking TherapeuticsCNBC’s Jim Cramer explains why he is keeping an eye on shares of Viking Therapeutics.
Persons: Jim Cramer Organizations: Therapeutics, Viking Therapeutics
VKTX YTD mountain Viking shares year to date Then, Viking shares more than doubled in trading on Tuesday, putting the stock on pace to report a more than 300% year-to-date gain, after the company said its GLP-1/GIP receptor agonist VK2735 hit all its primary goals in a phase 2 clinical trial. The Tema Cardiovascular and Metabolic ETF (HRTS) , which is up 12% year to date, owns Novo, Lilly and Viking. Still early days Some analysts and investors admit it is still very early days for obesity treatment and many questions remain to be answered. "We continue to expect above consensus growth in the space, as we are bullish on adoption from payers and broader obesity uptake," Meacham wrote. For obesity only, Lilly has already gained a 38% share, despite only being in the market for 13 weeks, he said.
Persons: Eli Lilly, Geoff Meacham, Meacham, Lilly, Yuri Khodjamirian, Khodjamirian, Jeff Jonas, Becton Dickinson, Novo, BofA's Meacham, What's, Tema's, it's, Gabelli's Jonas, he's, William Blair, Andy Hsieh, Hsieh Organizations: Novo Nordisk, Bank of America, Centers for Disease Control, Zealand Pharma, Viking Therapeutics, Zealand, Food and Drug Administration, Novo, Metabolic, Therapeutics, Pharmaceuticals, Rock, AstraZeneca, Roche, Gabelli Funds, FDA, Viking, Merck, Pfizer Locations: U.S, Tema, Novo Nordisk's, GLP, Lilly
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailViking's obesity drug study results are 'almost flawless', says Oppenheimer's Jay OlsonJay Olson, Oppenheimer biotech analyst, joins 'Fast Money' to talk Viking's best trading day ever and the results of its obesity drug study.
Persons: Oppenheimer's Jay Olson Jay Olson, Oppenheimer
Unity Software — Shares tumbled 15% after the video game developer forecasted that adjusted EBITDA would come in below analysts' expectations for the current quarter. Analysts polled by FactSet had expected $113 million in EBITDA, while Unity is expecting only between $45 million to $50 million. Workday's adjusted earnings came in at $1.57 a share, higher than the $1.47 expected by analysts polled by LSEG. AutoZone's earnings of $28.89 per share topped the $26.28 per share analysts had anticipated, according to LSEG. The company's $3.85 billion revenue was also higher than the anticipated $3.84 billion.
Persons: FactSet, LSEG, CarGurus, they'll, AutoZone, EBITDA, Wells, — CNBC's Michelle Fox, Tanaya Macheel, Sarah Min, Jesse Pound Organizations: Unity, LSEG, FactSet, PPG, Barclays, PPG Industries, FDA Locations: EBITDA, Cava, Wells Fargo, U.S, Canada
Norwegian Cruise Line — The cruise ship operator soared 18% on strong forward guidance. Unity expects adjusted EBITDA to range between $45 million and $50 million, versus the $113 million expected by analysts polled by FactSet. Viking Therapeutics — The clinical-stage biotech soared more than 90% after fulfilling primary and secondary endpoints in its Phase 2 GLP-1 study. Earnings came in at $1.57 per share, beating expectations of $1.47 per share, according to LSEG, formerly known as Refinitiv. Revenue of $1.92 billion matched analysts' expectations.
Persons: Viking, LSEG, Cava, Wells, Duolingo, CarGurus, — AutoZone, Microstrategy, , Sarah Min, Michelle Fox, Alex Harring, Jesse Pound, Yun Li Organizations: Cruise, Unity Software, FactSet, Therapeutics, Hess Corporation, Chevron, Exxon Mobil, China's, Offshore Oil Corp, Hess, Bank of America Securities, Seaport Research Partners, CleanSpark Locations: Cava
Total: 25